kaiser glp-1 coverage 2026 Medicare covers GLP-1s for $50/month starting July 📢 Two important dates for

Retatrutides purported results may be tempting, but experts agree that you should not purchase or use the drug now

March 1: The FDA on Friday granted full approval of J&Js Rybrevant in combination with chemotherapy as a first-line treatment for patients with non-small cell lung cancer (NSCLC) EGFR exon 20 insertion mutations, the company announced

Understanding the nuances of these disparities is imperative not only for clinicians but also for policymakers aiming to bridge gaps in chronic disease management

Here is what a typical daily protocol looks like: Month 1: 0.25 mL once daily (equivalent to the lowest starting dose) Month 2: 0.5 mL once daily (intermediate dose) Month 3+: 0.75 mL to 1.0 mL once daily (maintenance dose) The exact volumes depend on the concentration your pharmacy uses

The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction

Physical activity creates powerful signals for muscle preservation